Ibi-334 (Anti-B7-H3 & EGFR)
Product Specifications
Target
EGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Ibi-334 is an ADCC-enhanced bispecific antibody targeting B7-H3 and EGFR, showing potent preclinical efficacy in solid tumors. It blocks EGFR signaling while utilizing a finely tuned B7-H3 arm to enhance inhibition. M.W 145.58 kDa.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1047152-01 0.02 mg (E-Coli)
Recombinant Arthrobacter aurescens Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1047152-02 0.1 mg (E-Coli)
Recombinant Arthrobacter aurescens Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1047152-03 0.02 mg (Yeast)
Recombinant Arthrobacter aurescens Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1047152-04 0.1 mg (Yeast)
Recombinant Arthrobacter aurescens Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1047152-05 0.02 mg (Baculovirus)
Recombinant Arthrobacter aurescens Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1047152-06 0.02 mg (Mammalian-Cell)
Recombinant Arthrobacter aurescens Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details